The reverse stock split will take effect at 11:59 pm (Eastern Time) on June 11, 2025, and the Company's common stock will open for trading on The Nasdaq Capital Market on June 12, 2025 on a post ...

1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025. Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack ...

Potential Positives. The implementation of a 1-for-10 reverse stock split aims to increase the bid price of the company's common stock to help regain compliance with Nasdaq's minimum bid price ...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering ...

Potential Positives. The approval of a one-for-twenty-eight reverse stock split aims to increase the share price and bid price, aiding in compliance with Nasdaq's continued listing requirements.

Sensei Biotherapeutics announces a 1-for-20 reverse stock split effective June 16, 2025, to maintain Nasdaq compliance. Quiver AI Summary. Sensei Biotherapeutics, Inc. announced a 1-for-20 reverse ...

--FibroGen, Inc. today announced that it will implement a 1- for-25 reverse stock split of its issued and outstanding common stock, effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGen ...

AIM ImmunoTech announced a 1-for-100 reverse stock split effective June 12, 2025, to comply with NYSE requirements. Quiver AI Summary. AIM ImmunoTech Inc. announced a reverse stock split of 1-for ...

--Super League Enterprise, Inc., a leader in engaging audiences through playable media, content, and experiences within mobile games and the world’ s largest immersive platforms, announced today ...

Shuttle Pharmaceuticals Holdings, Inc. has announced a proposed reverse stock split of its common stock at a 25-for-1 ratio, which is subject to Nasdaq approval.

The reverse stock split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

FibroGen announced a 1-for-25 reverse stock split effective June 16, 2025, to increase stock price compliance on Nasdaq. Quiver AI Summary. FibroGen, Inc. announced a 1-for-25 reverse stock split ...